Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 40

Cat.No. Product Name Information/Activity
BCC6632 Spaglumic acid Spaglumic Acid is a neuropeptide found in millimolar concentrations in brain.
BCC6925 (RS)-APICA 170847-18-4
BCC6871 EGLU EGLU ((2S)-α-Ethylglutamic acid; (2S)-α-EGLU) is a potent and competitive mGluR-2 receptor antagonist. EGLU interacts with (lS,3S)-ACPD-sensitive site with a Kd value of 66 μM. EGLU is an antidepressant agent.
BCC1724 LY341495 LY341495 is a metabotropic glutamate receptor (mGluR) antagonist with IC50s of 2.9 nM, 10 nM, 170 nM for mGluR-2, mGluR-3, mGluR-8, respectively.
BCC6819 MSPG 169209-64-7
BCC6820 MTPG 169209-66-9
BCC7513 Ro 64-5229 246852-46-0
BCC7849 BINA Biphenylindanone A (BINA) is a selective human mGluR2 (hmGluR2) potentiator for the treatment of many neurological disorders.
BCC7824 CBiPES hydrochloride 856702-40-4
BCC7985 LY 2389575 hydrochloride 885104-09-6